CO2021003195A2 - Método de producción de derivados de 4-metoxipirrol - Google Patents

Método de producción de derivados de 4-metoxipirrol

Info

Publication number
CO2021003195A2
CO2021003195A2 CONC2021/0003195A CO2021003195A CO2021003195A2 CO 2021003195 A2 CO2021003195 A2 CO 2021003195A2 CO 2021003195 A CO2021003195 A CO 2021003195A CO 2021003195 A2 CO2021003195 A2 CO 2021003195A2
Authority
CO
Colombia
Prior art keywords
production method
methoxypyrrole derivatives
methoxypyrrole
derivatives
present disclosure
Prior art date
Application number
CONC2021/0003195A
Other languages
English (en)
Inventor
Jeong-Taek Shin
Deok Ki Eom
Jeong Hyun Son
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/KR2019/012122 external-priority patent/WO2020060213A1/ko
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Publication of CO2021003195A2 publication Critical patent/CO2021003195A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente divulgación se refiere a un método de fabricación de derivados de 4-metoxipirrol. La realización de la presente divulgación es útil para la producción industrial en masa de derivados de 4-metoxipirrol, ya que se mejoran el rendimiento y la eficiencia del procedimiento y se evita el uso de reactivos peligrosos y reactivos contaminantes para el medioambiente.
CONC2021/0003195A 2018-09-19 2021-03-11 Método de producción de derivados de 4-metoxipirrol CO2021003195A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180112196 2018-09-19
KR1020190110997A KR102126576B1 (ko) 2018-09-19 2019-09-06 4-메톡시 피롤 유도체의 제조 방법
PCT/KR2019/012122 WO2020060213A1 (ko) 2018-09-19 2019-09-19 4-메톡시 피롤 유도체의 제조 방법

Publications (1)

Publication Number Publication Date
CO2021003195A2 true CO2021003195A2 (es) 2021-04-08

Family

ID=69959291

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0003195A CO2021003195A2 (es) 2018-09-19 2021-03-11 Método de producción de derivados de 4-metoxipirrol

Country Status (21)

Country Link
US (1) US20210221770A1 (es)
EP (1) EP3854784A4 (es)
JP (1) JP7253624B2 (es)
KR (1) KR102126576B1 (es)
CN (1) CN112739684B (es)
AU (1) AU2019343857B2 (es)
BR (1) BR112021005156A2 (es)
CA (1) CA3110830A1 (es)
CL (1) CL2021000639A1 (es)
CO (1) CO2021003195A2 (es)
DO (1) DOP2021000042A (es)
EC (1) ECSP21019076A (es)
JO (1) JOP20210040A1 (es)
MA (1) MA53673A (es)
MX (1) MX2021003137A (es)
NZ (1) NZ773997A (es)
PE (1) PE20211736A1 (es)
PH (1) PH12021550523A1 (es)
RU (1) RU2763287C1 (es)
SG (1) SG11202101919VA (es)
TN (1) TN2021000035A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR20220088362A (ko) 2020-12-18 2022-06-27 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민을 포함하는 신규한 경구투여용 제제
KR102556500B1 (ko) * 2021-11-19 2023-07-19 하나제약 주식회사 피롤 유도체 또는 이의 약학적 또는 식품학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 위장 질환의 예방, 개선 또는 치료용 조성물
TW202411216A (zh) * 2022-05-23 2024-03-16 南韓商日東製藥股份有限公司 6-甲氧基吡啶-3-基衍生物之製造方法
WO2023229322A1 (ko) * 2022-05-23 2023-11-30 일동제약(주) 6-메톡시피리딘-3-일 유도체의 제조방법
CN117820193A (zh) * 2022-09-29 2024-04-05 安徽皓元药业有限公司 一种非苏拉赞盐酸盐晶型a及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048909B2 (en) * 2004-09-30 2011-11-01 Takeda Pharmaceutical Company Limited Proton pump inhibitors
WO2007114338A1 (ja) * 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited 酸分泌抑制薬
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
CA2891523A1 (en) * 2012-11-19 2014-05-22 Jiangsu Hansoh Pharmaceutical Co., Ltd. Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
JP2017071553A (ja) * 2014-02-25 2017-04-13 味の素株式会社 ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
CN104447491B (zh) * 2014-11-19 2017-06-23 连云港恒运医药有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途
KR101613245B1 (ko) * 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
CN106432191A (zh) * 2015-08-10 2017-02-22 陕西合成药业股份有限公司 一种新的吡咯类衍生物、其制备方法及其在医药上的应用
KR102081920B1 (ko) * 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
WO2017164575A1 (en) * 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine
CN107879964B (zh) * 2016-09-29 2023-02-10 江苏柯菲平医药股份有限公司 1-(5-(2-氟苯基)-1-(3-(3-甲氧丙氧基)苯磺酰氯)-1h-吡咯-3-基)-n-甲基胺的制备方法
CN108503621B (zh) * 2017-12-25 2021-09-14 上海中拓医药科技有限公司 一种富马酸沃诺拉赞的制备方法

Also Published As

Publication number Publication date
ECSP21019076A (es) 2021-05-31
KR102126576B1 (ko) 2020-06-24
TN2021000035A1 (en) 2022-10-03
DOP2021000042A (es) 2021-05-31
RU2763287C1 (ru) 2021-12-28
MA53673A (fr) 2022-03-30
MX2021003137A (es) 2021-05-14
CA3110830A1 (en) 2020-03-26
JP7253624B2 (ja) 2023-04-06
NZ773997A (en) 2024-03-22
AU2019343857A1 (en) 2021-04-15
PH12021550523A1 (en) 2022-02-21
CL2021000639A1 (es) 2021-08-06
EP3854784A1 (en) 2021-07-28
AU2019343857B2 (en) 2021-12-02
CN112739684A (zh) 2021-04-30
CN112739684B (zh) 2024-06-04
PE20211736A1 (es) 2021-09-06
KR20200033178A (ko) 2020-03-27
JOP20210040A1 (ar) 2021-03-07
US20210221770A1 (en) 2021-07-22
SG11202101919VA (en) 2021-04-29
JP2021535934A (ja) 2021-12-23
EP3854784A4 (en) 2022-03-30
BR112021005156A2 (pt) 2021-06-15

Similar Documents

Publication Publication Date Title
ECSP21019076A (es) Método de producción de derivados de 4-metoxipirrol
CL2018001790A1 (es) Procesos para preparar un inhibidor de jak1 y nuevas formas de este (divisional solicitud 201602748)
BR112019000718A2 (pt) processo para a produção de geopolímero ou compósito de geopolímero
PE20201263A1 (es) Suministro de cargas utiles a las celulas madre
AR101867A1 (es) Apuntalante curable a baja temperatura
BR112017000876A2 (pt) ?processo de fabricação de uma peça feita de material compósito de matriz de cerâmica, peça feita de material compósito de matriz de cerâmica, e, motor de turbina?
DOP2015000187A (es) Proceso de fabricación de vortioxetina
CL2020000869A1 (es) Enantiómeros de tiazoles sustituidos compuestos antivirales.
UY36557A (es) Composición ácida a base de leonardita y aminoácidos
CL2019000016A1 (es) Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble.
BR112021022071A2 (pt) Substrato pulverulento obtido por craqueamento a vapor de uma biomassa sem agente auxiliar químico e suas utilizações
CL2021001511A1 (es) Novedosa psicosa-6-fosfato fosfatasa, composición para la producción de psicosa que comprende la misma y procedimiento para la producción de psicosa mediante el uso de la misma
BR112017006470A2 (pt) processo para revestimento homogêneo de substratos (1) para a produção de catalisadores para purificação de gases de escapamento
CO2017005417A2 (es) Un procedimiento para formar 3-(4- isobutil-2-metil-fenil)propanal
CL2018002149A1 (es) Proceso.
AR113695A1 (es) Una d-psicosa 3-epimerasa y el uso de un método para producir d-psicosa
CU20170140A7 (es) Método para crear un compuesto a base de mercurio y el compuesto obtenido con el mismo
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
CO2021012174A2 (es) Microorganismo perteneciente al género staphylococcus que produce alulosa y procedimiento para la preparación de alulosa mediante el uso del mismo
UY37059A (es) Contenedores de vidrio de alta resistencia
BR112014018492A8 (pt) Processo aperfeiçoado para a produção de etileno 1,1-disubstituído
PE20142111A1 (es) Desactivacion microbial de composiciones explosivas
CL2019002319A1 (es) Microorganismo del género corynebacterium productor de l-arginina y método para producir l-arginina usando el mismo.
CO2018013033A2 (es) Grasa vacuna en polvo